Lawrence A Kenyon - Net Worth and Insider Trading
Lawrence A Kenyon Net Worth
The estimated net worth of Lawrence A Kenyon is at least $7,975 dollars as of 2024-04-28. Lawrence A Kenyon is the CEO, Pres, CFO, Treas & Secy of Outlook Therapeutics Inc and owns about 946 shares of Outlook Therapeutics Inc (OTLK) stock worth over $7,975. Details can be seen in Lawrence A Kenyon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lawrence A Kenyon has not made any transactions after 2021-04-20 and currently still holds the listed stock(s).
Transaction Summary of Lawrence A Kenyon
Lawrence A Kenyon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence A Kenyon owns 2 companies in total, including Outlook Therapeutics Inc (OTLK) , and Arno Therapeutics Inc (ARNI) .
Click here to see the complete history of Lawrence A Kenyon’s form 4 insider trades.
Insider Ownership Summary of Lawrence A Kenyon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2021-04-20 | CFO and Secretary |
| ARNI | Arno Therapeutics Inc | 2014-02-24 | Chief Financial Officer |
Lawrence A Kenyon Latest Holdings Summary
Lawrence A Kenyon currently owns a total of 1 stock. Lawrence A Kenyon owns 946 shares of Outlook Therapeutics Inc (OTLK) as of April 20, 2021, with a value of $7,975.
Latest Holdings of Lawrence A Kenyon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2021-04-20 | 946 | 8.43 | 7,975 |
Holding Weightings of Lawrence A Kenyon
Lawrence A Kenyon Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence A Kenyon has made a total of 3 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 500 shares on April 20, 2021, which cost Lawrence A Kenyon around $18,300.
Insider Trading History of Lawrence A Kenyon
- 1
Lawrence A Kenyon Trading Performance
GuruFocus tracks the stock performance after each of Lawrence A Kenyon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lawrence A Kenyon is -24.88%. GuruFocus also compares Lawrence A Kenyon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lawrence A Kenyon within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lawrence A Kenyon's insider trading performs compared to the benchmark.
Performance of Lawrence A Kenyon
Average Return
-42.34%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.29 | -24.88 | -24.46 | -42.34 | -31.62 | -40.89 |
| Relative Return to S&P 500(%) | 17.21 | -30.45 | -32.6 | -57.75 | -41.53 | -53.2 |
Lawrence A Kenyon Ownership Network
Ownership Network List of Lawrence A Kenyon
Ownership Network Relation of Lawrence A Kenyon
Lawrence A Kenyon Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Lawrence A Kenyon is the CFO and Secretary of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Lawrence A Kenyon made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net sale of 368,671 shares made by Jeff Evanson , a net sale of 520,000 shares made by Terry Dagnon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,006 shares, with a net purchase of 5,006 shares. During the past 18 months, 47,558 shares of Outlook Therapeutics Inc (OTLK) were sold and 5,006 shares were bought by its insiders, resulting in a net sale of 42,552 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Lawrence A Kenyon Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence A Kenyon. You might contact Lawrence A Kenyon via mailing address: C/o Outlook Therapeutics, Inc., 7 Clarke Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
